ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Program Manager, CMC at Immatics - ApplyBlast

Senior Program Manager, CMC

Immatics

7 days ago

3.6 on Glassdoor

Stafford, Texas, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Immatics is seeking a Senior Program Manager, CMC to lead cross-functional Chemistry, Manufacturing, and Controls activities within a cell therapy development and manufacturing environment. This role drives planning, execution, and integration across manufacturing, analytical, quality, regulatory, and supply chain functions to support clinical development and commercialization goals. The position serves as a strategic partner to technical and operational teams, ensuring alignment and readiness for key milestones including regulatory submissions and commercial manufacturing.

Responsibilities

Lead and coordinate cross-functional CMC activities across manufacturing, quality, and regulatory teams
Develop and maintain CMC program plans, timelines, and risk registers to support integrated execution
Coordinate and oversee activities with external vendors, CMOs, and CDMOs to ensure milestone readiness

Skills

About Immatics

immatics.com

Headquarters

Tübingen, Baden-Württemberg, Germany

Company Size

201-500 employees

Founded

2000

View Profile

Immatics is the global leader in precision targeting of PRAME, a cancer-associated antigen expressed in more than 50 cancer types. The company develops PRAME-targeted cell therapies (including TCR T-cell therapies) and TCR bispecific product candidates, with an active clinical pipeline spanning indications such as melanoma, lung, ovarian, breast, and endometrial cancers. Immatics combines deep expertise in immunology and drug development to advance novel treatments for patients with significant unmet medical need.